Calvin J. Kuo
Corporate Officer/Principal bei Stanford University School of Medicine
Profil
Calvin J.
Kuo is the founder of Surrozen Operating, Inc. (founded in 2015).
He is currently a Professor of Hematology at Stanford University School of Medicine.
Dr. Kuo holds a doctorate degree from Stanford University and an undergraduate degree from Harvard College.
Dr. Kuo is also the founder of TOMA Biosciences, Inc.
Aktive Positionen von Calvin J. Kuo
| Unternehmen | Position | Beginn |
|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Calvin J. Kuo
| Unternehmen | Position | Ende |
|---|---|---|
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Gründer | - |
TOMA Biosciences, Inc.
 TOMA Biosciences, Inc. Medical SpecialtiesHealth Technology TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA. | Gründer | - |
Ausbildung von Calvin J. Kuo
| Harvard College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
TOMA Biosciences, Inc.
TOMA Biosciences, Inc. Medical SpecialtiesHealth Technology TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
